Cargando…
Tocilizumab: Elevated AST and ALT following off label therapy: 11 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818710/ http://dx.doi.org/10.1007/s40278-021-89814-y |
Ejemplares similares
-
Remdesivir: Elevated AST and ALT levels following off-label therapy: 4 case reports
Publicado: (2020) -
Ribavirin: Mild elevation of bilirubin and AST/ALT: case report
Publicado: (2016) -
Remdesivir: Elevated ALT level and lack of efficacy following off-label use: 13 case reports
Publicado: (2021) -
Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report
Publicado: (2020) -
Dexamethasone/tocilizumab: Rhino-orbital mucormycosis following off-label use: 11 case reports
Publicado: (2021)